Ameritas Investment Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Ameritas Investment Partners’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,760	Closed	-$4.36K	–	3268
2023 Q1	$4.36K	Hold	3,760	–	–	﹤0.01%	2884
2022 Q4	$8.38K	Hold	3,760	–	–	﹤0.01%	2849
2022 Q3	$10K	Hold	3,760	–	–	﹤0.01%	2812
2022 Q2	$18K	Hold	3,760	–	–	﹤0.01%	2609
2022 Q1	$27K	Hold	3,760	–	–	﹤0.01%	2432
2021 Q4	$68K	Hold	3,760	–	–	﹤0.01%	1939
2021 Q3	$74K	Hold	3,760	–	–	﹤0.01%	1886
2021 Q2	$168K	Buy	+3,760	New	+$174K	0.01%	1382

Other funds holding CELL

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameritas Investment Partners's CELL Position: Q2 2023 in Review

Ameritas Investment Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 3,760 shares — an estimated $4.36K sold.

Ameritas Investment Partners first reported a position in CELL in Q2 2021 and held it in 8 quarters. The position peaked at $168K in Q2 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

Ameritas Investment Partners reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ameritas Investment Partners sold 3,760 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $4.36K.
Ameritas Investment Partners first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Ameritas Investment Partners's PhenomeX Inc. Common Stock position peaked at $168K in Q2 2021.
84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.